© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Baricitinib stands out in the pharmaceutical field as a selective inhibitor that targets Janus kinase enzymes, key players in inflammatory pathways. Used originally to manage rheumatoid arthritis, baricitinib earned a spotlight during the COVID-19 pandemic due to its ability to modulate the immune response. Chemically, it carries the formula C16H17N7O2S, which frames the core of its molecular structure and identifies its specific properties and activities.
This compound presents itself as a solid under normal conditions, usually found as a crystalline powder or flakes. Baricitinib has a molecular weight of about 371.42 g/mol. The molecule’s core includes nitrogen and sulfur atoms integrated with aromatic rings, granting it targeted enzyme binding power while delivering specific pharmacological effects. Its density measures approximately 1.5 g/cm³, which shapes how it is weighed, stored, and handled in bulk form. With a melting point close to 210°C, stability during transportation and production remains reliable, provided temperature controls are followed. Limited solubility in water is one more characteristic; baricitinib dissolves better in dimethyl sulfoxide and similar organic solvents. Pharmaceutical manufacturers rely on this data to choose compatible excipients for oral tablet formulations and injectable solutions.
Bulk quantities typically appear as off-white to light yellow powder or flaky solid. The fine particulate nature demands careful handling, with dust control measures in place during weighing and mixing steps in manufacturing. A dry, inert atmosphere works best for long-term storage, minimizing degradation. Crystal form not only makes identification more straightforward during quality control, but also assists in optimizing purification steps. Though not often produced as pearls or liquid solutions for transport, laboratory applications sometimes suspend the raw powder in solvents for chemical analysis. Each variant—solid, powder, or crystal—meets specific stages in the production pipeline, influencing how deeply the product undergoes further refinement.
Standard purity levels exceed 98% for pharmaceutical applications, confirmed through chromatographic methods. Uniform particle size enhances the precision of dosing, crucial for finished medicines. Trace contaminants—metal ions or residual solvents—fall below strict international limits, ensuring patient safety. The HS Code for baricitinib, as a pharmaceutical raw material, falls under 2934.99, reflecting its complex organic molecular structure. Proper labeling in storage areas highlights its status as an active pharmaceutical ingredient, steering warehouse teams and transporters toward careful handling during every logistical handoff.
Baricitinib, as with many synthetic organic compounds, presents both environmental and health risks if mishandled. Direct contact can cause mild skin or eye irritation. Dust exposure, if left uncontrolled, increases the risk of respiratory discomfort among workers. Strong safety measures—fume hoods, gloves, and protective eyewear—limit such risks. Mixing it with oxidizing chemicals should always be avoided, as unwanted reactions could arise. Proper segregation in storage areas reduces the chances of accidental contamination with incompatible materials. Large-scale facilities use vacuum transfer systems to prevent dusting and improve occupational safety.
As a pharmaceutical raw material, baricitinib’s lifecycle spans far beyond the laboratory. Attention to solvent recovery, dust collection, and wastewater treatment eases the environmental load. Manufacturers and labs alike dispose of expired or contaminated product through licensed hazardous waste handlers. Proper recordkeeping not only ensures compliance with environmental regulations but also helps communities avoid the pitfalls of pharmaceutical pollution. Developing clear protocols for incident response and first aid—well before scale-up—builds a workforce confident in managing both routine operations and the rare emergency.
A complete understanding of this compound’s attributes forms the backbone of pharmaceutical development and safe workplace practices. Accurate measurements of density, solubility, and crystal form guide every phase, from early formulation to final packaging and beyond. Industry professionals depend on these details every day, forging a global supply chain that links chemists, safety officers, logistics teams, and clinicians. For a molecule wielded against autoimmune disorders and emerging viral threats alike, nothing beats the power of knowledge rooted in careful observation, experience, and rigorous quality checks.
